Market Place
Sourcing Support
BMS, Merck, Amgen & more face near-term generic woes: Leerink
13 Nov 2024 //
FIERCE PHARMA
Amgen wins appeal in US patent case over generic psoriasis drugs
20 Apr 2023 //
REUTERS
Amgen v. Sanofi Praulent® Litigation Once Again on Appeal
15 Apr 2020 //
BIGMOLECULEWATCH
With 2019 sales sliding, Amgen CEO scored pay raise to $19.6M
08 Apr 2020 //
FIERCEPHARMA
CHMP Recommends One New Drug, Begins Review of Indian CRO
29 Feb 2020 //
RAPS
Litigation Update: Genentech’s Motion to Dismiss Amgen’s Counterclaims
14 Feb 2020 //
BIGMOLECULEWATCH
Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2019)
19 Dec 2019 //
PATENTDOCS
EY vet set to replace retiring Amgen CFO Meline
23 Oct 2019 //
ENDPTS
Amgen Inc. v. Coherus BioSciences Inc. (Fed. Cir. 2019)
12 Aug 2019 //
PATENTDOCS
Amgevita (Adalimumab) : Amgen vs. Coherus Biosciences
30 Jan 2019 //
PATENT LITIGATION
Supreme Court Denies Certiorari in Amgen v. Sanofi
17 Jan 2019 //
PATENT DOCS
Teva rolled its generic anyway—and then Amgen settled
04 Jan 2019 //
FIERCE PHARMA
Teva and Amgen Resolve Ongoing Dispute Over Teva’s Generic Cinacalet HCl Product
03 Jan 2019 //
BUSINESSWIRE
Jardiance (empagliflozin) : Boehringer Ingelheim vs. Zydus Pharms
20 Nov 2018 //
PATENT LITIGATION
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Sun Pharma
01 Nov 2018 //
PATENT LITIGATION
Teva’s sunny forecast for crucial Ajovy raises eyebrows on Wall Street
01 Nov 2018 //
FIERCE PHARMA
OrbiMed leads $60M launch of new NASH player
27 Oct 2018 //
ENDPTS
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
22 Oct 2018 //
RAPS
AbbVie settles Humira biosimilar dispute with Fresenius Kabi
19 Oct 2018 //
REUTERS
Teva`s patent failure gives long-acting Copaxone generics free rein
15 Oct 2018 //
FIERCE PHARMA
Abbvie settles Humira patent disputes with Novartis unit
11 Oct 2018 //
REUTERS
Was last week`s Teva sell-off warranted? Depends who you ask
03 Oct 2018 //
FIERCE PHARMA
Why This AbbVie Lawsuit Should Worry Broader Biopharma
20 Sep 2018 //
INVESTORS
Senispar (cinacalcet hydrochloride) : Amgen vs. Emcure Pharmaceuticals
15 Sep 2018 //
PATENT LITIGATION
With clock ticking on Teva migraine drug, analyst expresses doubt for approval
07 Sep 2018 //
FIERCE PHARMA
BPCIA Litigation Updates: Bevacizumab, Trastuzumab, Filgrastim
17 Aug 2018 //
BIGMOLECULEWATCH
Raviciti® (glycerol phenylbutyrate) : Horizon Therapeutics v. Par Pharmaceutical
11 Aug 2018 //
PATENT LITIGATION
Neupogen (Filgrastim), Neulasta® (pegfilgrastim) : Amgen Inc. v. Apotex Corp.
11 Aug 2018 //
PATENT LITIGATION
Amneal obtains non-infringement finding in Sensipar case
02 Aug 2018 //
LIFESCIENCE PREVIEW
NEUPOGEN® (filgrastim): Amgen Inc. v. Hospira Inc. and Pfizer Inc.
23 Jul 2018 //
PATENT LITIGATION
DUEXIS® (Ibuprofen and Famotidine): Horizon Pharma, Inc. and Horizon Pharma USA, Inc. v. Alkem Laboratories Ltd.
11 Jul 2018 //
PATENT LITIGATION
Senispar® (cinacalcet hydrochloride): Amgen Inc. v. Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd.
29 Jun 2018 //
PATENT LITIGATION
The top 15 patent expirations of 2018
03 Apr 2018 //
FIERCE PHARMA
Amgen faces one-two blow from Repatha, Sensipar competition
14 Mar 2018 //
FIERCE PHARMA
Neupogen® (Filgrastim): Amgen v. Adello Biologics
08 Mar 2018 //
PATENT LITIGATION
Amgen comes up short in Sensipar lawsuit against FDA
22 Feb 2018 //
FIERCE PHARMA
Novartis joins biosimilar Humira push in US
16 Jan 2018 //
PMLIVE
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
15 Jul 2017 //
REUTERS
Novartis gets European OK for biosimilar of Amgen`s Enbrel
27 Jun 2017 //
REUTERS
U.S. Supreme Court ruling gives biosimilar drugs a boost
18 Jun 2017 //
Sensipar® (Cinacalcet Hydrochloride): Amgen Inc. V. Piramal Healthcare Limited
09 Jun 2017 //
PATENT LITIGATION
Pennsaid® (Diclofenac Sodium ): Horizon Pharma & HZNP V. Actavis Laboratories
11 May 2017 //
PATENT LITIGATION
Neulasta® (Pegfilgrastim): Amgen Inc.V. Coherus Biosciences Inc.
10 May 2017 //
PATENT LITIGATION
Dupixent (Dupilumab): Immunex v. Sanofi Genzyme, Aventisub LLC, & Regeneron
05 Apr 2017 //
PATENT LITIGATION
Drugmakers Turn Cheap Generics Into Expensive Pills
31 Oct 2016 //
WALL STREET
Generic Drugs Stocks Under Scanner -- Mylan, Horizon, Allergan, & Catalent
22 Oct 2016 //
PRNEWSWIRE
Biosimilar makers lose second shot at shortening biologics exclusivity
06 Jul 2016 //
FIERCE PHARMA
Horizon targets points of care to triumph over generic RA rivals
18 May 2016 //
FIERCE MARKETING
Generic drug ETF ailing despite political focus on high drug prices
03 Mar 2016 //
REUTERS
J&J: Biosimilars will not replicate generic levels of competition or substitution
15 Sep 2015 //
BIOPHARMA-REPORTER
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
22 Jul 2015 //
FIERCE PHARMA MARKETING
Celltrion Seeks FDA Approval for Biosimilar Remsima
01 Apr 2015 //
FIRST WORLD PHARMA
Intas Pharmaceuticals Launches INTACEPT, The First Etanercept Biosimilar
28 Mar 2015 //
THE FINANCIAL EXPRESS
